Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)
South Korea · Delayed Price · Currency is KRW 145,100
+6,100 (4.39%)
Feb 9, 2026, 9:18 AM KST
Mezzion Pharma Market Cap
Mezzion Pharma has a market cap or net worth of 4.22 trillion as of February 6, 2026. Its market cap has increased by 364.11% in one year.
Market Cap
4.22T
Enterprise Value
4.20T
Revenue
7.75B
Ranking
n/a
PE Ratio
n/a
Stock Price
145,100.00
Market Cap Chart
Since January 20, 2012, Mezzion Pharma's market cap has increased from 240.02B to 4.22T, an increase of 1,658.41%. That is a compound annual growth rate of 22.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 4.22T | 54.27% |
| Dec 30, 2025 | 2.74T | 195.96% |
| Dec 30, 2024 | 924.37B | -19.89% |
| Dec 28, 2023 | 1.15T | 231.92% |
| Dec 29, 2022 | 347.65B | -82.01% |
| Dec 30, 2021 | 1.93T | 23.60% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HK inno.N | 1.50T |
| G2GBIO | 1.31T |
| Myung In Pharmaceutical LTD. | 903.74B |
| ImmuneOncia Therapeutics | 719.40B |
| Samyang Biopharm | 696.00B |
| HEM Pharma | 633.63B |
| CellBion | 324.00B |
| DAE HWA Pharmaceutical | 264.85B |